相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Progress in adjuvant systemic therapy for breast cancer
Noam F. Ponde et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src/CD155/MIF functional pathway
Wen-Chien Huang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Slc6a8-Mediated Creatine Uptake and Accumulation Reprogram Macrophage Polarization via Regulating Cytokine Responses
Liangliang Ji et al.
IMMUNITY (2019)
Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance
Monish Ram Makena et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer A Review
Kathryn C. Arbour et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC
Lai Wei et al.
NATURE COMMUNICATIONS (2019)
Wnt Signaling in Ovarian Cancer Stemness, EMT, and Therapy Resistance
Miriam Teeuwssen et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models
Ioanna Keklikoglou et al.
NATURE CELL BIOLOGY (2019)
HMGB1-containing nucleosome mediates chemotherapy-induced metastasis of human lung cancer
Kailing Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Cancer incidence and mortality in China, 2014
Wanqing Chen et al.
CHINESE JOURNAL OF CANCER RESEARCH (2018)
Chemotherapy-induced metastasis: mechanisms and translational opportunities
George S. Karagiannis et al.
CLINICAL & EXPERIMENTAL METASTASIS (2018)
PHGDH is an independent prognosis marker and contributes cell proliferation, migration and invasion in human pancreatic cancer
Zhiwang Song et al.
GENE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Lung cancer: current therapies and new targeted treatments
Fred R. Hirsch et al.
LANCET (2017)
Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism
George S. Karagiannis et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Discoidin, CUB and LCCL domain-containing protein 2 (DCBLD2) is a novel biomarker of myxofibrosarcoma invasion identified by global protein expression profiling
Kazutaka Kikuta et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2017)
Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles
Antonio Rossi et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2016)
Non-small cell lung cancer: current treatment and future advances
Cecilia Zappa et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
Host effects contributing to cancer therapy resistance
Ofrat Beyar Katz et al.
DRUG RESISTANCE UPDATES (2015)
Personalizing Colon Cancer Adjuvant Therapy: Selecting Optimal Treatments for Individual Patients
Rodrigo Dienstmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy
Wendy Onstenk et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Identification of tumour suppressive microRNA-451a in hypopharyngeal squamous cell carcinoma based on microRNA expression signature
I. Fukumoto et al.
BRITISH JOURNAL OF CANCER (2014)
EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis
Haizhong Feng et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Treatment-induced host-mediated mechanisms reducing the efficacy of antitumor therapies
L. G. M. Daenen et al.
ONCOGENE (2014)
MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cells
Jean-Philippe Guegan et al.
CARCINOGENESIS (2013)
Transmembrane protein ESDN promotes endothelial VEGF signaling and regulates angiogenesis
Lei Nie et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Maintenance Chemotherapy for Advanced Non-Small-Cell Lung Cancer: New Life for an Old Idea
David E. Gerber et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Ensemble of Gene Signatures Identifies Novel Biomarkers in Colorectal Cancer Activated through PPAR gamma and TNF alpha Signaling
Stefano Maria Pagnotta et al.
PLOS ONE (2013)
Expression of AP-2α, AP-2γ and ESDN in primary melanomas: Correlation with histopathological features and potential prognostic value
Simona Osella-Abate et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2012)
Potential Association of DCBLD2 Polymorphisms with Fall Rates of FEV1 by Aspirin Provocation in Korean Asthmatics
Tae-Joon Park et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2012)
First-Line Systemic Therapy Practice Patterns and Concordance With NCCN Guidelines for Patients Diagnosed With Metastatic NSCLC Treated at NCCN Institutions
Carrie Zornosa et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)
DCBLD2 Gene Variations Correlate with Nasal Polyposis in Korean Asthma Patients
Charisse Flerida A. Pasaje et al.
LUNG (2012)
Mesenchymal Stem Cells Induce Resistance to Chemotherapy through the Release of Platinum-Induced Fatty Acids
Jeanine M. L. Roodhart et al.
CANCER CELL (2011)
A Wnt Survival Guide: From Flies to Human Disease
Andy J. Chien et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Identification of novel neuroendocrine-specific tumour genes
E. Hofsli et al.
BRITISH JOURNAL OF CANCER (2008)
Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial
Jean-Yves Pierga et al.
CLINICAL CANCER RESEARCH (2008)
Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion
Mirang Kim et al.
MOLECULAR CANCER RESEARCH (2008)
CLCP1 interacts with semaphorin 4B and regulates motility of lung cancer cells
H. Nagai et al.
ONCOGENE (2007)
Neo-adjuvant chemotherapy in non-small cell lung cancer (NSCLC)
A. Santo et al.
ANNALS OF ONCOLOGY (2006)
Expression of kinase suppressor of Ras1 enhances cisplatin-induced extracellular signal-regulated kinase activation and cisplatin sensitivity
M Kim et al.
CANCER RESEARCH (2005)
Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress
J Hayakawa et al.
MOLECULAR CELL (2004)
Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy
SY El Sharouni et al.
BRITISH JOURNAL OF CANCER (2003)
Ras-mediated activation of ERK by cisplatin induces cell death independently of p53 in osteosarcoma and neuroblastoma cell lines
W Woessmann et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivo
K Koshikawa et al.
ONCOGENE (2002)
ESDN, a novel neuropilin-like membrane protein cloned from vascular cells with the longest secretory signal sequence among eukaryotes, is up-regulated after vascular injury
K Kobuke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Role of mitogen-activated protein kinases in the response of tumor cells to chemotherapy
MY Fan et al.
DRUG RESISTANCE UPDATES (2001)
Requirement for ERK activation in cisplatin-induced apoptosis
XT Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
